CCR5 and HIV-1 infection: For example, the CCR5Δ32 homozygous genotype was first identified in two EUs with reduced susceptibility to HIV-1 infection [15], but has since been associated with protection in Caucasians [17] and has led to the development of CCR5-targeting drugs [46].